Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.

Tsapepas D, Chiles M, Babayev R, Rao MK, Jaitly M, Salerno D, Mohan S.

Am J Med. 2016 Dec;129(12):1322-1328. doi: 10.1016/j.amjmed.2016.07.012. Epub 2016 Aug 16.

PMID:
27542610
2.

Retrospective investigation of side effects and prognoses of moderate-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia that developed in patients with autoimmune diseases.

Shibata T, Tonooka K, Tsuchida K, Mitomi H, Shibata T, Katsuyama N.

Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):213-8. doi: 10.2177/jsci.39.213.

3.

Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.

Higashioka K, Niiro H, Yoshida K, Oryoji K, Kamada K, Mizuki S, Yokota E.

Intern Med. 2016;55(5):467-71. doi: 10.2169/internalmedicine.55.5697. Epub 2016 Mar 1.

4.

[Cotrimoxazole in bone-related infections: toxicity and clinical and economic impact].

Fíca A, Lamas C, Olivares F, Ramírez D, Soto A, Porte L, Braun S, Vlllablanca I.

Rev Chilena Infectol. 2015 Dec;32(6):609-17. doi: 10.4067/S0716-10182015000700001. Spanish.

5.

Hyperkalemia.

Palmer BF, Clegg DJ.

JAMA. 2015 Dec 8;314(22):2405-6. doi: 10.1001/jama.2015.9230. No abstract available.

PMID:
26647263
6.

ACP Journal Club. Trimethoprim-sulfamethoxazole was linked to sudden death in older patients using spironolactone.

Ananthakrishnan S.

Ann Intern Med. 2015 Jun 16;162(12):JC13. doi: 10.7326/ACPJC-2015-162-12-013. No abstract available.

PMID:
26075778
7.

Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.

Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

CMAJ. 2015 Mar 3;187(4):E138-43. doi: 10.1503/cmaj.140816. Epub 2015 Feb 2.

8.

Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study.

Fralick M, Macdonald EM, Gomes T, Antoniou T, Hollands S, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

BMJ. 2014 Oct 30;349:g6196. doi: 10.1136/bmj.g6196.

9.

Intraoperative hyperkalemia induced by administration of trimethoprim-sulfamethoxazole in a patient receiving angiotensin receptor blockers.

Lee SW, Park SW, Kang JM.

J Clin Anesth. 2014 Aug;26(5):427-8. doi: 10.1016/j.jclinane.2014.03.003. Epub 2014 Aug 13. No abstract available.

PMID:
25128254
10.

Hyponatraemia associated with trimethoprim use.

Khow KS, Yong TY.

Curr Drug Saf. 2014 Mar;9(1):79-82.

PMID:
24372181
11.
12.

Life-threatening hyperkalemia: a potentially lethal drug combination.

Juvet T, Gourineni VC, Ravi S, Zarich SW.

Conn Med. 2013 Sep;77(8):491-3.

PMID:
24156179
13.
14.

Trimethoprim-induced hyperkalemia in burn patients treated with intravenous or oral trimethoprim sulfamethoxazole for methicillin-resistant Staphylococcus aureus and other infections: nature or nurture?

Ackerman BH, Patton ML, Guilday RE, Haith LR Jr, Stair-Buchmann M, Reigart CL.

J Burn Care Res. 2013 Jan-Feb;34(1):127-32. doi: 10.1097/BCR.0b013e3182700b18.

PMID:
23292580
15.

[Case of trimethoprim-induced hyperkalemia complicating ANCA-associated vasculitis].

Shishido T, Ryuzaki M, Futatsugi K, Takimoto C, Kobayashi E, Handa M, Itoh H.

Nihon Jinzo Gakkai Shi. 2012;54(5):615-21. Japanese.

PMID:
22991842
16.

Considerations when prescribing trimethoprim-sulfamethoxazole.

Ho JM, Juurlink DN.

CMAJ. 2011 Nov 8;183(16):1851-8. doi: 10.1503/cmaj.111152. Epub 2011 Oct 11. Review. No abstract available.

17.

Co-prescription of co-trimoxazole and spironolactone in elderly patients.

Wei L, MacDonald TM, Mackenzie IS.

BMJ. 2011 Sep 12;343:d5656. doi: 10.1136/bmj.d5656. No abstract available.

PMID:
21911447
18.

Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.

Antoniou T, Gomes T, Mamdani MM, Yao Z, Hellings C, Garg AX, Weir MA, Juurlink DN.

BMJ. 2011 Sep 12;343:d5228. doi: 10.1136/bmj.d5228.

19.

Trimethoprim-sulfamethoxazole-induced hyponatremia.

Dunn RL, Smith WJ, Stratton MA.

Consult Pharm. 2011 May;26(5):342-9. doi: 10.4140/TCP.n.2011.342.

PMID:
21733815
20.

Life threatening hyperkalemia chronic kidney diseases patients treated with trimethoprim-sulfamethoxazole: a case series.

Calderón-Ortiz R, Colton-Verge P, Muñiz-Ortega M, Lespier L, Córdova H.

Bol Asoc Med P R. 2011 Jul-Sep;103(3):15-7.

PMID:
23210327

Supplemental Content

Loading ...
Support Center